Cargando…

Neuroprotective effect of liraglutide in an experimental mouse model of multiple sclerosis: role of AMPK/SIRT1 signaling and NLRP3 inflammasome

The heterogeneous nature of multiple sclerosis (MS) and the unavailability of treatments addressing its intricate network and reversing the disease state is yet an area that needs to be elucidated. Liraglutide, a glucagon-like peptide-1 analogue, recently exhibited intriguing potential neuroprotecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ammar, Reham A., Mohamed, Ahmed F., Kamal, Mohamed M., Safar, Marwa M., Abdelkader, Noha F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135867/ https://www.ncbi.nlm.nih.gov/pubmed/35364735 http://dx.doi.org/10.1007/s10787-022-00956-6

Ejemplares similares

Cilostazol Alleviates NLRP3 Inflammasome–Induced Allodynia/Hyperalgesia in Murine Cerebral Cortex Following Transient Ischemia: Focus on TRPA1/Glutamate and Akt/Dopamine/BDNF/Nrf2 Trajectories
por: Zaki, Omnia S., et al.
Publicado: (2022)

Liraglutide ameliorates myocardial damage in experimental diabetic rats by inhibiting pyroptosis via Sirt1/AMPK signaling
por: Zhang, Zhe, et al.
Publicado: (2021)

Dapagliflozin as an autophagic enhancer via LKB1/AMPK/SIRT1 pathway in ovariectomized/d-galactose Alzheimer’s rat model
por: Ibrahim, Weam W., et al.
Publicado: (2022)

Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis‐related NLRP3 pathway
por: Song, Shuang, et al.
Publicado: (2022)

Role of NLRP3 inflammasome in systemic sclerosis
por: Lin, Cong, et al.
Publicado: (2022)

Neuroprotective Effect of Oridonin on Traumatic Brain Injury via Inhibiting NLRP3 Inflammasome in Experimental Mice
por: Yan, Chaolong, et al.
Publicado: (2020)

FNDC5 Attenuates Oxidative Stress and NLRP3 Inflammasome Activation in Vascular Smooth Muscle Cells via Activating the AMPK-SIRT1 Signal Pathway
por: Zhou, Bing, et al.
Publicado: (2020)

A Novel Role of Irbesartan in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats: Targeting DDAH/ADMA and EGFR/ERK Signaling
por: Shahin, Nancy N., et al.
Publicado: (2018)

Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke
por: Ismael, Saifudeen, et al.
Publicado: (2018)

Amentoflavone Affects Epileptogenesis and Exerts Neuroprotective Effects by Inhibiting NLRP3 Inflammasome
por: Rong, Shikuo, et al.
Publicado: (2019)

GPA peptide inhibits NLRP3 inflammasome activation to ameliorate colitis through AMPK pathway
por: Deng, Zhao, et al.
Publicado: (2020)

Ischemic Preconditioning Provides Neuroprotection by Inhibiting NLRP3 Inflammasome Activation and Cell Pyroptosis
por: Gao, Li, et al.
Publicado: (2023)

Role of SIRT1 in Hepatic Encephalopathy: In Vivo and In Vitro Studies Focusing on the NLRP3 Inflammasome
por: Jiao, Fangzhou, et al.
Publicado: (2021)

Neuroprotective Effects of Liraglutide for Stroke Model of Rats
por: Sato, Kenichiro, et al.
Publicado: (2013)

Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy
por: Yang, Fan, et al.
Publicado: (2019)

Mangiferin Ameliorates HFD-Induced NAFLD through Regulation of the AMPK and NLRP3 Inflammasome Signal Pathways
por: Yong, Zhang, et al.
Publicado: (2021)

Amyloid‐β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk‐AMPK pathway
por: Jung, Eun Sun, et al.
Publicado: (2022)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Spotlight on the NLRP3 inflammasome pathway
por: Groslambert, Marine, et al.
Publicado: (2018)

Shikonin Ameliorates LPS-Induced Cardiac Dysfunction by SIRT1-Dependent Inhibition of NLRP3 Inflammasome
por: Guo, Tao, et al.
Publicado: (2020)

Colchicine Ameliorates Dilated Cardiomyopathy Via SIRT2‐Mediated Suppression of NLRP3 Inflammasome Activation
por: Sun, Xuan, et al.
Publicado: (2022)

SIRT1 Inhibits High Glucose–Induced TXNIP/NLRP3 Inflammasome Activation and Cataract Formation
por: Lian, Lili, et al.
Publicado: (2023)

Sinensetin Attenuated Macrophagic NLRP3 Inflammasomes Formation via SIRT1-NRF2 Signaling
por: Lin, Lin, et al.
Publicado: (2023)

Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage
por: Xia, Dayong, et al.
Publicado: (2023)

The NLRP1 inflammasome in skin diseases
por: Burian, Marc, et al.
Publicado: (2023)

The role of the NLRP3 inflammasome in gout
por: Kingsbury, Sarah R, et al.
Publicado: (2011)

Curcumin Ameliorates Age-Induced Tight Junction Impaired in Porcine Sertoli Cells by Inactivating the NLRP3 Inflammasome through the AMPK/SIRT3/SOD2/mtROS Signaling Pathway
por: Xiao, Longfei, et al.
Publicado: (2023)

Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics
por: Cui, Yueran, et al.
Publicado: (2022)

Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway
por: Ma, Chongyang, et al.
Publicado: (2019)

Metformin Protects against Spinal Cord Injury and Cell Pyroptosis via AMPK/NLRP3 Inflammasome Pathway
por: Yuan, Yajiang, et al.
Publicado: (2022)

Corrigendum: Amyloid‐β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk‐AMPK pathway
Publicado: (2022)

Inhibition of the NLRP3 inflammasome provides neuroprotection in rats following amygdala kindling-induced status epilepticus
por: Meng, Xiang-Fei, et al.
Publicado: (2014)

Neuroprotective Effect of Dexmedetomidine against Postoperative Cognitive Decline via NLRP3 Inflammasome Signaling Pathway
por: Cho, Inja, et al.
Publicado: (2022)

Itaconate Attenuates Neuroinflammation and Exerts Dopamine Neuroprotection in Parkinson’s Disease through Inhibiting NLRP3 Inflammasome
por: Sun, Guoqing, et al.
Publicado: (2022)

SIRT1 agonism modulates cardiac NLRP3 inflammasome through pyruvate dehydrogenase during ischemia and reperfusion
por: Han, Ying, et al.
Publicado: (2020)

Tetrandrine alleviates cerebral ischemia/reperfusion injury by suppressing NLRP3 inflammasome activation via Sirt-1
por: Wang, Jun, et al.
Publicado: (2020)

Neurodegenerative Disease and the NLRP3 Inflammasome
por: Holbrook, Jonathan A., et al.
Publicado: (2021)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway
por: Zhang, Jing, et al.
Publicado: (2020)

Salidroside Suppresses the Proliferation and Migration of Human Lung Cancer Cells through AMPK-Dependent NLRP3 Inflammasome Regulation
por: Ma, Weidong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8f3rttdao5pujfvglcp83kiac1